High-throughput virus quantification using cytopathic effect area analysis by deep learning
Murphy, M.; Mazur, S.; Postnikova, E. N.; Eaton, B. P.; Kocher, G. A.; Chu, W.; Lackemeyer, M. G.; Gilani, S. Q.; Kuhn, J. H.; Holbrook, M. R.; Morris, C. P.
Show abstract
Traditional infectivity-based virion quantification methods, such as 50% tissue culture infectious dose (TCID50) and plaque assays, are typically performed in 6-, 12-, 24-, or 48-well cell culture plates and require manual work and analysis based on legacy protocols. Adaptation of these methods to high-throughput formats (96-, 384- or 1,536-well plates) is challenging due to both assay automation constraints and the lack of well surface area available for reliable analysis. Here, we present a scalable alternative to traditional methods that uses whole-well image thresholding to quantify infectious virions by measuring virus-induced cytopathic effect (CPE) via cell lysis and detachment. The CPE area assay is best positioned as a practical high-throughput preliminary screening tool, effectively quantifying samples within the assay range and flagging samples above or below the concentration thresholds. To improve analysis efficiency and reduce user bias in CPE area selection, we evaluated an nnU-Net model for automated image segmentation against images segmented by manually defined brightness thresholds. The model achieved perfect correlation with manual thresholding (R2=1.00), showing minimal differences in the identified CPE area and thus validating nnU-Net as a reliable alternative to manual analysis. This approach provides two complementary pipelines: manual thresholding, which tolerates adjustments of hyperparameters, and fully automated segmentation via nnU-Net, which streamlines analysis and enhances throughput. This flexible CPE area assay enables accurate and automated quantification in high-throughput screening formats, thereby greatly accelerating a routine laboratory task while decreasing subjectivity and bias. Author summaryMeasuring the amount of virus in a biosample is a critical part of viral research and testing of new treatments. Traditional methods are slow, labor-intensive, and not easily scaled up to handle large numbers of samples. In this study, we developed a new approach that makes the process faster, more efficient, scalable, and less reliant on manual steps. We used microscopy imaging to capture how cells respond to virus infections and analyzed these images automatically to identify and measure areas where the virus had damaged cells. The analysis pipeline allows researchers to fine-tune settings or run the process using machine learning. This method is flexible and adaptable to a variety of viruses and experiments. By increasing the number of samples that can be tested at once while reducing the time and effort needed for analysis, our approach has the potential to accelerate research in virology, drug development, and public health.
Matching journals
The top 7 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Choosing the right tool for the job: A comprehensive assessment of serological assays for SARS-CoV-2 as surrogates for authentic virus neutralization 94%
- Detection of Mpox and other Orthopoxviruses using a Lateral Flow Device as a Point of Care diagnostic. 94%
- CRISPR/Cas14a Combined with RPA for Visual Detection of Marek's Disease Virus 93%
Similar papers in this journal
- Scalable, Micro-Neutralization Assay for Qualitative Assessment of SARS-CoV-2 (COVID 19) Virus-Neutralizing Antibodies in Human Clinical Samples 95%
- OraSure InteliSwab ® Rapid Antigen Test performance with the SARS-CoV-2 Variants of Concern Alpha, Beta, Gamma, Delta, and Omicron 95%
- Propagation, inactivation, and safety testing of SARS-CoV-2 94%
Similar papers in this journal
- Development of a Novel Medium Throughput Flow-Cytometry Based Micro-Neutralisation Test for SARS-CoV-2 with Applications in Clinical Vaccine Trials and Antibody Screening 93%
- Sequencing SARS-CoV-2 from Antigen Tests 92%
- Multicenter international assessment of a SARS-CoV-2 RT-LAMP test for point of care clinical application 92%
Similar papers in this journal
- A Fast and Accessible Method for the Isolation of RNA, DNA, and Protein to Facilitate the Detection of SARS-CoV-2 94%
- Inactivation analysis of SARS-CoV-2 by specimen transport media, nucleic acid extraction reagents, detergents and fixatives 93%
- Metagenomic Nanopore sequencing of influenza virus direct from clinical respiratory samples 92%
Similar papers in this journal
- Deployable CRISPR-Cas13a diagnostic tools to detect and report Ebola and Lassa virus cases in real-time 94%
- Development and Implementation of a scalable and versatile test for COVID-19 diagnostics in rural communities 94%
- A high-throughput neutralizing antibody assay for COVID-19 diagnosis and vaccine evaluation 93%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.